The MAPK-AP-1/-Runx2 signalling axes are implicated in chondrosarcoma pathobiology either independently or via up-regulation of VEGF

Histopathology

Volumn 47, Issue 6, 2005, Pages 565-574

  Papachristou, D J ^a,b   Papachristou, G J ^a   Papaefthimiou, O A ^b   Agnantis, N J ^b   Basdra, E K ^c   Papavassiliou, Athanasios G ^a  

^a UNIVERSITY OF PATRAS   (Greece)

^b UNIVERSITY OF IOANNINA   (Greece)

^c ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

AP 1; Chondrosarcoma; MAP kinase; Runx2 Cbfa1; Signal transduction; VEGF

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN C FOS; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR RUNX2; VASCULOTROPIN;

ADULT; AGED; ARTICLE; CANCER GRADING; CARCINOGENESIS; CARTILAGE CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; CHONDROSARCOMA; CONTROLLED STUDY; ENCHONDROMA; ENZYME PHOSPHORYLATION; ENZYME SUBSTRATE; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; PATHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; UPREGULATION;

ADULT; AGED; CELL TRANSFORMATION, NEOPLASTIC; CHONDROSARCOMA; CORE BINDING FACTOR ALPHA 1 SUBUNIT; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MITOGEN-ACTIVATED PROTEIN KINASES; RETROSPECTIVE STUDIES; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR AP-1; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 28844448789     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2005.02266.x     Document Type: Article

References (45)

1. Bertoni F, Bacchini P, Hogendoorn PCW. Chondrosarcoma. In Fletcher CDM, Unni KK, Mertens F eds. Pathology and genetics of soft tissue and bone. Lyon: IARC Press 2002; 247-251.
2. Unni KK. Cartilaginous lesions of bone. J. Orthop. Sci. 2001; 6; 457-472.
3. Culver JE, Sweet DE, McCue FC. Chondrosarcoma of the hand arising from a pre-existent benign solitary enchondroma. Clin. Orthop. Relat. Res. 1975; 113; 128-131.
4. Remagen W, Nidecker A, Dolanc B. Case report 368. Skeletal Radiol. 1986; 15; 330-333.
5. van Beerendonk H, Rozeman LB, Taminiau AHM et al. Molecular analysis of the INK4A/INK4A-ARF gene locus in conventional (central) chondrosarcomas and enchondromas: indication of an important gene for tumour progression. J. Pathol. 2004; 202; 359-366.
6. Asp J, Sangiogi L, Inerot SE et al. Changes of the p16 gene but not the p53 gene in human chondrosarcoma tissues. Int. J. Cancer 2000; 85; 782-786.
7. Bovee JV, Sciot R, Cin PD et al. Chromosome 9 alterations and trisomy 22 in central chondrosarcoma: a cytogenetic and DNA flow cytometric analysis of chondrosarcoma subtypes. Diagn. Mol. Pathol. 2001; 10; 228-235.
8. Wong M, Carter DR. Articular cartilage functional histomorphology and mechanobiology: a research perspective. Bone 2003; 33; 1-13.
9. Angel P, Karin M. The role of Jun, Fos and the AP-1 complex in cell proliferation and transformation. Biochim. Biophys. Acta 1991; 1072; 129-257.
10. Eferl R, Wagner EF. AP-1: a double-edged sword in tumourigenesis. Nature Rev. Cancer 2003; 3; 859-868.
11. Papachristou DJ, Batistatou A, Sykiotis GP, Varakis I, Papavassiliou AG. Activation of the JNK-AP-1 signal transduction pathway is associated with pathogenesis and progression of human osteosarcomas. Bone 2003; 32; 364-371.
12. D'Alonzo RC, Selvamurugan N, Karsenty G, Partridge NC. Physical interaction of the activator protein-1 factors c-Fos and c-Jun with Cbfa1 for collagenase-3 promoter activation. J. Biol. Chem. 2002; 277; 816-822.
13. Ziros PG, Rojas-Gil A-P, Georgakopoulos T, Habeos I, Basdra EK, Papavassiliou AG. The bone-specific transcriptional regulator Cbfa1 is a target of mechanical signals in osteoblastic cells. J. Biol. Chem. 2002; 277; 23934-23941.
14. Ducy P. Cbfa1: a molecular switch in osteoblast biology. Dev. Dyn. 2000; 219; 461-471.
15. Kronenberg HM. Developmental regulation of growth plate. Nature 2003; 423; 332-336.
16. Enomoto H, Enomoto-Iwamoto M, Iwamoto M et al. Cbfa1 is a positive regulatory factor in chondrocyte maturation. J. Biol. Chem. 2000; 275; 8695-8702.
17. Kim IS, Otto F, Zabel B, Mundlos S. Regulation of chondrocyte differentiation by Cbfa1. Mech. Dev. 1999; 80; 159-170.
18. Stricker S, Fundele R, Vortkamp A, Mundlos S. Role of Runx genes in chondrocyte differentiation. Dev. Biol. 2002; 245; 95-108.
19. Hicklin DJ, Ellis LM. Role of vascular endothelial growth factor pathway in tumor growth and angiogenesis. J. Clin. Oncol. 2005; 23; 1-17.
20. Weider N. Tumoral vascularity as a prognostic factor in cancer patients: the evidence continues to grow. J. Pathol. 1998; 184; 119-122.
21. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature 2000; 407; 249-257.
22. Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat. Med. 2003; 9; 669-676.
23. Ferrara N, Alitalo K. Clinical applications of angiogenic growth factors and their inhibitors. Nat. Med. 1999; 5; 1359-1364.
24. McDonald NQ, Hendrickson WA. A structural superfamily of growth factors containing a cystine knot motif. Cell 1993; 73; 421-424.
25. Furumatsu T, Nishida K, Kawai A, Namda M, Inoue H, Ninomiya Y. Human chondrosarcoma secrets VEGF to induce tumor angiogenesis and stores basic fibroblast growth factor for regulation of its own growth. Int. J. Cancer 2002; 3; 313-322.
26. Ayala G, Liu C, Nicosia R, Horowitz S, Lackman R. Microvasculature and VEGF expression in cartilaginous tumors. Hum. Pathol. 2000; 3; 341-346.
27. McGough RL, Lin C, Meitner P, Aswad BI, Terek RM. Angiogenetic cytokines in cartilage tumors. Clin. Orthop. 2002; 397; 62-69.
28. Lin C, McGough R, Aswad B, Block JA, Terek R. Hypoxia induces HIF-1a and VEGF expression in chondrosarcoma cells and chondrocytes. J. Orthop. Res. 2004; 22; 1175-1181.
29. Xu L, Fukumura D, Jain RK. Acidic extracellular pH induces vascular endothelial growth factor (VEGF) in human glioblastoma cells via ERK1/2 MAPK signalling pathway. J. Biol. Chem. 2002; 277; 11368-11374.
30. Feng H, Xiang H, Mao Y-M et al. Human Bcl-2 activates ERK signalling pathway to regulate activating protein-1, lens epithelium-derived growth factor and downstream genes. Oncogene 2004; 23; 7310-7321.
31. Salnikov K, Kluz T, Costa M et al. The regulation of hypoxic genes by calcium involves c-Jun/AP-1, which cooperates with hypoxia-inducible factor-1 in response to hypoxia. Mol. Cell. Biol. 2002; 22; 1734-1741.
32. Zelzer E, Glotzer DJ, Hartman C et al. Tissue specific regulation of VEGF expression during bone development requires Cbfa1/ Runx2. Mech. Dev. 2001; 106; 97-106.
33. Stanton LE, Underbill TM, Beier F. MAP kinases in chondroblastic differentiation. Dev. Biol. 2003; 263; 165-175.
34. Shramek H. MAP kinases: from intracellular signals to physiology and disease. News Physiol. Sci. 2002; 17; 62-67.
35. Kyriakis JM, Avruch J. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol. Rev. 2001; 81; 807-869.
36. Whitmarsh AJ, Davis RJ. Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways. J. Mol. Med. 1996; 74; 589-607.
37. 2-terminal kinase-2-deficient mice. Cancer Res. 2001; 61; 3908-3912.
38. Licato LL, Brenner DA. Analysis of signaling protein kinases in human colon or colorectal carcinomas. Dig. Dis. Sci. 1998; 43; 1454-1464.
39. Wulf GM, Ryo A, Wulf GG et al. Pin1 is overexpressed in breast cancer and cooperates with Ras signalling in increasing the transcriptional activity of c-Jun towards cyclin D1. EMBO J. 2001; 20; 3459-3472.
40. 2-terminal kinase in oncogenic ras-induced morphologic transformation of human lung carcinoma cells. Cancer Res. 2000; 60; 400-408.
41. McMahon G. VEGF receptor signalling in tumor angiogenesis. Oncologist 2000; 5; 3-10.
42. Hoeben A, Landuyt BL, Highley MS, Wildiers H, van Oosterom AT, Bruijn EA. Vascular endothelial growth factor and angiogenesis. Pharmacol. Rev. 2004; 56; 549-580.
43. McGough RL, Aswad BI, Terek RM. Pathologic neovascularization in cartilage tumors. Clin. Orthop. 2002; 397; 76-82.
44. Fujioka S, Niu J, Schmidt C et al. NF-κB and AP-1 connection: mechanisms of NF-κB-dependent regulation of AP-1 activity. Mol. Cell. Biol. 2004; 24; 7806-7819.
45. Bjornsson J, McLeod RA, Unni KK, Ilstrup DM, Pritchard DJ. Primary chondrosarcoma of long bones and limb girdles. Cancer 1998; 83; 2105-2119.